Adrock, unfortunately I agree with you that there won't be any fluticare approved announcement on Monday, because I don't think that fluticare has been approved.
The reason why the 2nd stock payment was made, was probably because that was INNV's guestimate date of fluticare being approved, so that's why they just paid it, otherwise the company wouldn't have allowed INNV to buy fluticare, if they had to wait so long, that was probably part of the deal.
I think the FDA will more than likely drag out the fluticare review until 12/31/17 and then reject it, due to a missing period on the last sentence of the NDA, then it will take another 3 years to review and then it will finally get rejected in 2020, because it's too risky, too addictive and too chemically dangerous, per the FDA.
News 
Market Data 
Discover 
